Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 57


Alcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinence.

García ML, Blasco-Algora S, Fernández-Rodríguez CM.

World J Gastroenterol. 2015 Jul 28;21(28):8516-26. doi: 10.3748/wjg.v21.i28.8516. Review.


Alcohol-induced dysregulation of stress-related circuitry: The search for novel targets and implications for interventions across the sexes.

Retson TA, Sterling RC, Van Bockstaele EJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 May 23. pii: S0278-5846(15)00099-8. doi: 10.1016/j.pnpbp.2015.05.009. [Epub ahead of print]


Disulfiram attenuates osteoclast differentiation in vitro: a potential antiresorptive agent.

Ying H, Qin A, Cheng TS, Pavlos NJ, Rea S, Dai K, Zheng MH.

PLoS One. 2015 Apr 30;10(4):e0125696. doi: 10.1371/journal.pone.0125696. eCollection 2015.


Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram.

DeVito EE, Babuscio TA, Nich C, Ball SA, Carroll KM.

Drug Alcohol Depend. 2014 Dec 1;145:156-67. doi: 10.1016/j.drugalcdep.2014.10.007. Epub 2014 Oct 20.


PTSD and comorbid AUD: a review of pharmacological and alternative treatment options.

Ralevski E, Olivera-Figueroa LA, Petrakis I.

Subst Abuse Rehabil. 2014 Mar 7;5:25-36. doi: 10.2147/SAR.S37399. eCollection 2014. Review.


Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatment.

Wackernah RC, Minnick MJ, Clapp P.

Subst Abuse Rehabil. 2014 Jan 23;5:1-12. doi: 10.2147/SAR.S37907. eCollection 2014. Review.


Therapy for alcoholic liver disease.

Jaurigue MM, Cappell MS.

World J Gastroenterol. 2014 Mar 7;20(9):2143-58. doi: 10.3748/wjg.v20.i9.2143. Review.


Pharmacotherapy of alcohol use disorders: seventy-five years of progress.

Zindel LR, Kranzler HR.

J Stud Alcohol Drugs Suppl. 2014;75 Suppl 17:79-88. Review.


Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis.

Skinner MD, Lahmek P, Pham H, Aubin HJ.

PLoS One. 2014 Feb 10;9(2):e87366. doi: 10.1371/journal.pone.0087366. eCollection 2014.


A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy.

Spivak AM, Andrade A, Eisele E, Hoh R, Bacchetti P, Bumpus NN, Emad F, Buckheit R 3rd, McCance-Katz EF, Lai J, Kennedy M, Chander G, Siliciano RF, Siliciano JD, Deeks SG.

Clin Infect Dis. 2014 Mar;58(6):883-90. doi: 10.1093/cid/cit813. Epub 2013 Dec 12.


Dopamine β-hydroxylase inhibitors enhance the discriminative stimulus effects of cocaine in rats.

Manvich DF, DePoy LM, Weinshenker D.

J Pharmacol Exp Ther. 2013 Dec;347(3):564-73. doi: 10.1124/jpet.113.207746. Epub 2013 Sep 25.


Glutamatergic targets for new alcohol medications.

Holmes A, Spanagel R, Krystal JH.

Psychopharmacology (Berl). 2013 Oct;229(3):539-54. doi: 10.1007/s00213-013-3226-2. Epub 2013 Sep 1. Review.


Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone.

Froehlich JC, Hausauer BJ, Rasmussen DD.

Alcohol Clin Exp Res. 2013 Oct;37(10):1763-70. doi: 10.1111/acer.12148. Epub 2013 Jul 22.


Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review.

Brennan JL, Leung JG, Gagliardi JP, Rivelli SK, Muzyk AJ.

Clin Pharmacol. 2013 Jul 3;5:99-107. doi: 10.2147/CPAA.S32434. Print 2013.


Medications for substance use disorders.

Douaihy AB, Kelly TM, Sullivan C.

Soc Work Public Health. 2013;28(3-4):264-78. doi: 10.1080/19371918.2013.759031. Review.


Treatment of co-occurring alcohol and other drug use disorders.

Arias AJ, Kranzler HR.

Alcohol Res Health. 2008;31(2):155-67. Review.


Treatment implications: using neuroscience to guide the development of new pharmacotherapies for alcoholism.

Krishnan-Sarin S, O'Malley S, Krystal JH.

Alcohol Res Health. 2008;31(4):400-7. Review.


Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response.

Gueorguieva R, Wu R, Krystal JH, Donovan D, O'Malley SS.

Addict Behav. 2013 May;38(5):2119-27. doi: 10.1016/j.addbeh.2013.01.024. Epub 2013 Feb 4.


Safety and efficacy of acamprosate for the treatment of alcohol dependence.

Yahn SL, Watterson LR, Olive MF.

Subst Abuse. 2013;6:1-12. doi: 10.4137/SART.S9345. Epub 2013 Jan 31.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk